p53 immunoreactivity as prognostic marker for cancer-specific survival in prostate cancer

European Urology

Volumn 30, Issue 1, 1996, Pages 65-72

  Stattin, P ^a   Bergh, A ^a   Karlberg, L ^a   Nordgren, H ^a   Damber, J E ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Immunohistochemistry; p53; Prognostic marker; Prostate cancer; Surveillance; Survival; Transurethral resection

Indexed keywords

MARKER; PROTEIN P53;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC VALUE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; TRANSURETHRAL RESECTION; TUMOR DIFFERENTIATION;

EID: 0030035620     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474147     Document Type: Article

References (0)